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Genetic and epigenetic features direct differential
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Xist is indispensable for X chromosome inactivation. However, how Xist RNA directs
chromosome-wide silencing and why some regions are more efﬁciently silenced than others
remains unknown. Here, we explore the function of Xist by inducing ectopic Xist expression
from multiple different X-linked and autosomal loci in mouse aneuploid and female diploid
embryonic stem cells in which Xist-mediated silencing does not lead to lethal functional
monosomy. We show that ectopic Xist expression faithfully recapitulates endogenous X
chromosome inactivation from any location on the X chromosome, whereas long-range
silencing of autosomal genes is less efﬁcient. Long interspersed elements facilitate inacti-
vation of genes located far away from the Xist transcription locus, and genes escaping X
chromosome inactivation show enrichment of CTCF on X chromosomal but not autosomal
loci. Our ﬁndings highlight important genomic and epigenetic features acquired during sex
chromosome evolution to facilitate an efﬁcient X chromosome inactivation process.
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In mammals, dosage compensation of sex chromosomal genesbetween females (XX) and males (XY) is achieved through Xchromosome inactivation (XCI). XCI starts with the mono-
allelic upregualtion of the X-linked non-coding gene Xist and
culminates in the conversion of one entire X chromosome into a
silent heterochromatic entity known as the Barr body (Xi)1, 2.
During XCI, Xist RNA spreads in cis and recruits a multitude of
factors involved in trancriptional inactivation. The Xi is initially
depleted of euchromatic histone modiﬁcations such as H3K4me2/
me3 and H3/H4 acetylation, and subsequently enriched for
repressive marks such as H3K27me3 and H2AK119ub3–6.
Although Xist is the major player of the process7–10, the mole-
cular mechanisms by which Xist RNA spreads along the chro-
mosome and triggers gene silencing remains largely unknown.
Several X;autosome translocation studies showed incomplete
inactivation of the autosomal material11–14, suggesting a
sequence-speciﬁc model for Xist spreading. In this context, long
interspersed elements (LINE) have been proposed to work as
“way stations” for X-linked-speciﬁc Xist spreading15. LINEs are
enriched on both human and mouse X chromosomes relative to
autosomes and take part in the formation of the Xi silent com-
partment3, 16. However, LINE-rich genomic areas correspond to
gene-poor areas, whereas gene-rich areas are depleted of LINEs.
Thus, the preferential spreading of Xist RNA in LINE-rich
regions of autosomes may reﬂect negative selection against
cells in which Xist-mediated silencing leads to functional
aneuploidy14, 16–18. In addition, speciﬁc X-linked regions that are
targeted by Xist RNA at the onset of XCI are not enriched for
LINEs, thus questioning their role in conferring X chromosome
speciﬁcity to Xist spreading19, 20.
Around 3–7% of mouse X-linked genes escape from XCI21.
To date, how these genes can remain transcriptionally active within
the silent Xi remains largely unknown. Escaping genes lack the
epigenetic marks typical of inactivated genes and retain active
marks22, 23. Furthermore, they are located outside the Xist RNA
domain3, 24, have been suggested to be intrinsically competent to
resist XCI25, and to be ﬂanked by cis-acting elements that protect
neighboring genes from escape26. CTCF has been proposed to play
a role in XCI escape both acting as a boundary element between
active and inactive loci27 or as an anchor that allows looping out of
active domains from the Xi territory28, 29.
Unraveling Xist’s functions is critical for a complete under-
standing of XCI. Here, to address the mechanism(s) directing
Xist-mediated silencing, we set up a doxycycline-responsive Xist
expression system in mouse embryonic stem cell (ESC) lines. By
inducing ectopic XCI from several genomic regions in kar-
yotypically normal and abnormal ESC lines, we discovered that:
(I) Xist’s silencing efﬁciency is locus dependent, (II) speciﬁc X-
linked but not autosomal loci are intrinsically prone to become
inactivated or to escape XCI, (III) LINEs facilitate gene silencing
but are unlikely to work as X-speciﬁc way stations, and (IV)
CTCF plays a X-speciﬁc role in directing XCI escape.
Results
An inducible Xist expression system in mouse ESC lines. To
assess the efﬁciency of Xist-mediated silencing from several
genomic contexts, we set up a doxycycline-responsive expression
system in F1 2–1 ESC lines (129/Sv-Cast/Ei). First, we generated
an Xist-inducible transgene using a Cast/Ei bacterial artiﬁcial
chromosome (BAC) covering 300 kb of the X chromosome
including the Xist endogenous locus. Through homologous
recombination in bacteria30, 1 kb upstream of Xist transcription
starting site (TSS) was replaced with a targeting cassette carrying
a Ptight bidirectional doxycycline-responsive promoter driving
Xist and a DsRed reporter gene (Fig. 1). Next, the Xist-inducible
transgene was transfected into F1 2–1 female ESCs in which the
reverse tetracycline transactivator M2rtTA had been targeted at
the ROSA26 locus (Supplementary Fig. 1A, B). Neomycin-
resistant ESCs were screened by either restriction fragment
length polymorphism (RFLP)-PCR or DNA ﬂuorescent in situ
hybridization (FISH), and four sets of transgenic female ESC lines
were selected: (1) Tg-E clones, in which the Xist transgene was
targeted to the Xist endogenous locus of the Cast/Ei X chromo-
some of a wild-type ESC line (40,XX). Four independent Tg-E
clones were generated (68, 87, 77, 64), in which successful
homologous recombination of the transgene was assessed by
RFLP-PCR (Fig. 1a; Table 1). (2) Tg-X;8 and (3) Tg-X clones, in
which the Xist transgene was randomly integrated on either X
chromosomes of a karyotypically abnormal ESC line carrying two
intact copies of chromosome 8 and a duplication of the distal
two-thirds of the Cast/Ei chromosome 8, which is fused to the
129/Sv X chromosome in the resulting X;8 translocation (40,XX,t
(X;8)) (Supplementary Fig. 1C). We generated three independent
Tg-X;8 clones (339, 203b, 267), with the Xist transgene integrated
at different loci on the X;8 translocation product, and four
independent Tg-X clones (85, 86, 109, 190) carrying the Xist
transgene on the wild-type Cast/Ei X chromosome (Fig. 1d, e;
Table 1). Finally (4), we generated six independent Tg-12 clones
(251, 292, 228, 160, 55, 273), in which the Xist transgene was
randomly integrated at different loci of one copy of chromosome
12 in a trisomic ESC line (41,XX,dup12) (Fig. 1f, g; Table 1). All
Tg-X;8, Tg-X, and Tg-12 clones were initially selected by DNA
FISH using chromosomes X, 8, and 12-speciﬁc probes, followed
by targeted locus ampliﬁcation31 to determine the exact site of
integration (Table 1).
Ectopic Xist RNA spreads in cis on chromosomes. Next, we
asked whether ectopic Xist could be efﬁciently expressed upon
doxycycline induction and whether the induced Xist RNA could
spread in cis on chromosomes X, 12, and 8. To this end, all ESC
clones were grown in ESC medium supplemented with doxycy-
cline for 5 days. By inducing ectopic XCI in undifferentiated
ESCs, we were able to uncouple Xist function from cell differ-
entiation, thus allowing the efﬁciency of Xist spreading to be
assessed independently of any selection on cell viability. Xist RNA
could be ectopically expressed from both the X chromosome and
autosomes, with the inducible system showing no leakiness of Xist
expression (Fig. 2a–d). Tg-X;8 clone 267 and Tg-12 clone 160
carry a previously described Tsix-Stop allele32 on the 129/Sv X
chromosome, which explains the higher level of basal Xist
expression in untreated conditions. This Tsix-Stop allele is pre-
sent in the original lines as a ﬂoxed allele and was removed in all
clones except clones 267 and 160 upon Cre-mediated removal of
the neo selection cassette. Xist RNA enrichment in doxycycline-
treated cells vs. untreated cells varies from 10- to 250-fold in
between different clones (Fig. 2a–d). In spite of this variability,
the enrichment of ectopic Xist in ESCs is either comparable or
higher than the one reached by endogenous Xist upon neuronal
differentiation of untreated ESCs (Supplementary Fig. 2A). In
fact, endogenous Xist is upregulated by 3- to 70-fold between day
2 and day 4 of differentiation, when XCI starts, compared to
undifferentiated ESCs, prior to XCI (Supplementary Fig. 2A).
To assess whether ectopic Xist RNA is stable and can spread in cis
from different loci, we performed Xist RNA FISH on all trans-
genic clones after 5 days of doxycycline induction (Fig. 2e–k).
About 50–70% of induced cells showed an Xist-coated chromo-
some (Fig. 2e–h) which was stable over time (Supplementary
Fig. 2B, C). Taken together, this data demonstrate that we set up a
robust Xist expression system to separate Xist RNA function from
genomic context and cell differentiation and without any
aneuploidy-related phenotype.
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X-linked genes are more efﬁciently silenced than autosomes.
To assess whether ectopic Xist RNA could trigger gene silencing
independently of its genomic position, we performed RNA-seq
analysis of Tg-E, Tg-X, Tg-X;8 and Tg-12 clones after 5 days of
doxycycline treatment in undifferentiated ESCs. We generated
52 RNA-seq libraries including two biological replicates per clone
in both doxycycline- treated and untreated conditions. Total
RNA-seq reads were aligned to both the 129/Sv and the Cast/Ei
parental genomes and the abundance of allele-speciﬁc reads was
estimated by summing up the number of 129- and Cast-speciﬁc
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Fig. 1 Generation of a tetracycline-responsive Xist expression system in ES cells. a Targeting strategy to generate Tg-E clones. The Xist TSS was replaced
with a bidirectional tetracycline-responsive Ptight promoter, a DsRed reporter gene, and a neomycin resistance cassette. b PCR ampliﬁcation with primers
indicated in a followed by a Tsp509I RFLP digest of PCR product to identify clones with a correctly targeted Cast/Ei allele. Correct targeting results in loss
of Cast/Ei-speciﬁc band, as shown for clones 7, 41, and 56. Arrows indicate size of PCR product and Tsp509I restriction fragments. F1 F1 2-1 polymorphic
129/Sv-Cast/Ei mother cell line, M marker, H water. c PCR ampliﬁcation of a fragment of the X-linked gene Atrx and Pf1MI digest of the PCR product to
verify the presence of two X chromosomes. Arrows indicate size of PCR product and size of Pf1MI restriction fragments. d, f Schematic representation of the
strategy used to generate Tg-X, Tg-X;8 d, and Tg-12 clones f. The Xist transgene was randomly integrated into F1 2-1 40,XX,t(X;8) or 41,XX,dup12 ESC
lines and neomycin-resistant clones were screened by DNA FISH. e, g DNA FISH screening of Tg-X, Tg-X;8 e, and Tg-12 g clones. Arrows indicate the
chromosome carrying the Xist transgene. Positive Tg-X;8 clones show co-localization of three DNA FISH signals on the translocated X;8 chromosome
corresponding to the Xist endogenous locus, the ectopic transgene, and the chromosome 8 portion of the X;8 translocation. Three independent ES clones
were generated (267, 339, 203b). Positive Tg-X clones show two DNA FISH signals on the wild-type Cast/Ei X corresponding to the endogenous Xist locus
and to the ectopic transgene, respectively. Four independent ES clones were generated (86, 190, 85, 109). Positive Tg-12 clones show co-localization of two
DNA FISH signals on one of the three copies of chromosome 12, corresponding to the Xist-inducible transgene and to chromosome 12, respectively. Six
independent ES clones have been generated (251, 160, 273, 292, 55, 228). Scale bars represent 5 μm
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00528-1 ARTICLE
NATURE COMMUNICATIONS |8:  690 |DOI: 10.1038/s41467-017-00528-1 |www.nature.com/naturecommunications 3
reads of all exonic single-nucleotide polymorphism (SNPs) within
the gene33. For each gene in our data set, we used the total counts
of 129/Sv (N129) and Cast/Ei (NCast) allele-speciﬁc reads to obtain
the ratio of Cast-speciﬁc gene expression (Cast/all ratio= (NCast)/
(NCast +N129)). Only polymorphic sites showing a coverage equal
to or higher than ﬁve reads were treated as informative. For genes
containing a single polymorphic site, the coverage threshold was
increased to eight reads. In Tg-E clones, in which the inducible
transgene is targeted at the Xist endogenous locus of the Cast/Ei X
chromosome, the overall X-linked gene expression changes
from biallelic expression (ratio= 0.5) in untreated cells to a more
129/Sv-monoallelic gene expression (ratio< 0.5) in doxycycline-
treated cells. Since ectopic XCI can be induced in only 60–70% of
doxycycline- treated ESCs (Fig. 2e–h), we consider all genes that
show a Δ ratio between 0.1 and 0.5 to be affected by Xist RNA
(Fig. 3a, b), resulting in silencing of 60–70% of all X-linked genes
(Fig. 3a, b), and highlighting efﬁcient ectopic XCI when Xist is
induced from its endogenous locus. Similarly, in Tg-X and Tg-X;8
clones, X-linked gene expression upon doxycycline induction
shifts from biallellic (ratio= 0.5) to either more 129- or Cast-
monoallelic expression according to which of the two X chro-
mosomes carries the Xist transgene. Thus, Tg-X clones 85, 86,
109, 190 show inactivation of the wild-type Cast/Ei X chromo-
some (ratio< 0.5), whereas in Tg-X;8 clones 203b, 267, and 339
the 129/Sv X chromosome portion of the X;8 translocation pro-
duct is inactivated upon doxycycline Xist induction (ratio> 0.5)
(Fig. 3c, h). Due to the presence of a Tsix-stop allele32, clone 267
already showed a bias toward Cast-monoallelic gene expression in
untreated conditions. Silencing of X-linked genes is slightly
reduced when compared to Tg-E clones, but did not differ a lot
between Tg-X and Tg-X;8 clones, ranging from 35 to 65%
(Fig. 3d–i). This indicated that silencing of X-linked genes
induced from Xist transgenes located on X chromosomal and
autosomal sequences works equally well.
Next, we tested whether ectopic Xist RNA could silence
autosomal genes, focusing on chromosome 12 and 8 gene
expression upon Xist induction in Tg-12 and Tg-X;8 clones,
respectively. Tg-12 clones carry three chromosomes 12, one of
129/Sv, and two of Cast/Ei origin. Therefore, the Cast/all
expression ratio is close to 0.66 in doxycycline-untreated clones.
This allele-speciﬁc ratio shifts in either one or the other direction
according to which of the three chromosome 12 carries the
transgene. Clone 55 shows the highest efﬁciency of gene
inactivation with 26% of chromosome 12 genes becoming
silenced, whereas in clones 292 and 273 the expression of
only 15% of the autosomal genes is affected by Xist induction
(Fig. 3f).
Similar results were found for Tg-X;8 clones, in which gene
expression of the trisomic portion of chromosome 8 shifts from a
Cast/all ratio of 0.66 in doxycycline-untreated cells to biallelic
gene expression upon Xist induction (ratio< 0.66), with variable
efﬁciency in between different clones (Fig. 3g–i). However, in Tg-
X;8 clones 203b, 267, and 339, the inactivation of the autosomal
portion of the X;8 translocation product is less pronounced than
the X-chromosomal counterpart (Fig. 3i). In fact, only 15–25% of
autosomal genes are affected by Xist induction, which is
signiﬁcantly less than observed for cis-linked X-chromosomal
genes (Fig. 3i). Importantly, chromosome 8 gene expression does
not show any change upon Xist induction in Tg-X clones, thus
excluding any impact of doxycycline treatment on gene
expression (Supplementary Fig. 3A). The RNA-seq results were
validated by real-time PCR analysis followed by pyrosequencing
(Supplementary Fig. 3B, C). Taken together, our ﬁndings suggest
that ectopic Xist RNA can cis-inactivate X-linked genes
independently of the locus from which it is induced, even when
induced from autosomal sequences. In contrast, Xist’s silencing
ability of autosomal genes is reduced, suggesting the presence of
X-linked sequences or epigenetic features that favor silencing of
X-linked genes.
Xist-mediated silencing upon ESC differentiation. In all
experiments described so far, ESCs were grown in culture media
supplemented with leukemia inhibitory factor (LIF) and inhibi-
tors of the MAPK and Gsk3β pathways (“2i” culture conditions),
which stabilize the pluripotent ground state34, 35. Furthermore,
ectopic XCI in pluripotent ESCs relies on constant Xist expression
and gene inactivation becomes irreversible only upon ESC dif-
ferentiation36. Based on these observations, we asked whether 2i
culture conditions and cell differentiation might have an impact
on Xist’s silencing efﬁciency. First, we performed a time course
experiment in which Tg-E and Tg-12 ESC clones were grown in
more “primed” serum + LIF culture conditions supplemented
with doxycycline for 6 days. This transfer did not reveal any effect
on gene silencing efﬁciency (Fig. 3j, k; Supplementary Fig. 3D, E).
In Tg-E clones, Rnf12, Abcb7, and Pgk1 were consistently silenced
Table 1 Summary of transgenic clones generated in this study
Clone Category Chr. Allele Karyotype 5′–3′ Integration sites (mm10) Additional information
87 Tg-E X Cast 40,XX chrX:103,460,373-103,483,217 Xist promoter 1 kb del (Cast)
68 Tg-E X Cast 40,XX chrX:103,460,373-103,483,217 Xist promoter 1 kb del (Cast)
64 Tg-E X Cast 40,XX chrX:103,460,373-103,483,217 Xist promoter 1 kb del (Cast)
77 Tg-E X Cast 40,XX chrX:103,460,373-103,483,217 Xist promoter 1 kb del (Cast)
267 Tg-X:8 X:8 129 40,XX,t(X;8) chr8:110,645,220-110,329,507 Tsix-Stop allele (129)
339 Tg-X:8 X:8 129 40,XX,t(X;8) ND –
203b Tg-X:8 X:8 129 40,XX,t(X;8) chr8:122,340,941-122,343,259 –
86 Tg-X X Cast 40,XX,t(X;8) chrX:134,402,074a-134,559,764 –
190 Tg-X X Cast 40,XX,t(X;8) chrX:169,976,922a-170,005,736a –
85 Tg-X X Cast 40,XX,t(X;8) ~chrX telomere –
109 Tg-X X Cast 40,XX,t(X;8) chrX:103,483,223a-103,484,258a –
251 Tg-12 12 ND 41,XX,dup12 ND –
292 Tg-12 12 Cast 41,XX,dup12 chr12:89,465,956a-89,155,600 –
228 Tg-12 12 Cast 41,XX,dup12 chr12:109,077,348-109,113,528 –
160 Tg-12 12 Cast 41,XX,dup12 ~chr12 centromere Tsix-Stop allele (129)
55 Tg-12 12 129 41,XX,dup12 chr12:104,543,748a-104,556,010 –
273 Tg-12 12 Cast 41,XX,dup12 chr12:98,483,300a-98,489,700 –
TLA targeted locus ampliﬁcation
aDue to the features of the integration locus and/or the Xist transgene sequence, the initial TLA experiment did not yield the exact integration site, but did allow to make the approximation indicated
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at each tested time point (Fig. 3j; Supplementary Fig. 3D).
In Tg-12 clones, the efﬁciency of gene inactivation is more het-
erogeneous with clones 55 and 273 showing silencing of three out
of four tested genes at each time point of the experiment (Nampt,
Tcl1, and Pole2), whereas in clone 228 only Pole2 and Tcl1 are
affected by Xist induction and clone 292 showed very poor
silencing for all tested genes (Fig. 3k; Supplementary Fig. 3E).
Next, we differentiated all ESC clones into neurons (Supple-
mentary Fig. 4A, B). Upon neuronal differentiation of Tg-E
clones, the X-linked genes Rnf12 and Abcb7 showed increased
skewing toward monoallelic-129/Sv expression in doxycycline-
treated cells compared to ectopic XCI triggered in undifferen-
tiated ESCs (day 0) (Fig. 3l). In contrast, when we followed
allele-speciﬁc expression of chromosome 12 genes throughout
neuronal differentiation of Tg-12 clones, we conﬁrmed silencing
efﬁciencies to be higher for clones 55, 273, and 160 compared to
228 and 292, but silencing efﬁciency did not increase upon
neuronal differentiation (Fig. 3m; Supplementary Fig. 3F). Allele-
speciﬁc Xist quantitative PCR conﬁrmed that Xist-inducible
transgenes remained expressed throughout differentiation in all
Tg-12 clones (Supplementary Fig. 3G). However, we cannot
exclude that the poor gene silencing observed for clones 292 and
228 might be due to the integration sites of Xist transgenes
relative to the few loci we tested in our single-gene silencing assay.
Therefore, we performed RNA-seq analysis at day 14 of neuronal
differentiation of clones 292 and 55, showing poor and
robust Xist-mediated silencing of chromosome 12, respectively
(Fig. 3n, o). Chromosome-wide analysis of clone 55 conﬁrmed
efﬁcient gene inactivation of chromosome 12 upon Xist induction
although the proportion of genes that are affected by Xist did not
signiﬁcantly increase compared to what we observed in
undifferentiated ESCs (Fig. 3o, f). Similarly, overall inactivation
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Fig. 2 Ectopic Xist RNA induction in undifferentiated ES cells. qPCR quantiﬁcation of Xist RNA in clones a Tg-E (68, 87), b Tg-X;8 (203b, 267, 339), c Tg-X
(109, 190, 86, 85), and d Tg-12 (228, 251, 273, 292, 55-38, 160) after 5 days of doxycycline treatment. Data of two independent experiments are shown
(e–h). Quantiﬁcation of Xist RNA FISH experiments in clones Tg-X (85, 109, 190, 86) e, Tg-E (64, 77, 87) f, Tg-12 (55, 228, 273, 292, 251) g, and Tg-X;8
(203b, 339, 267) h after 5 days of doxycycline induction. n> 100 nuclei counted per ES clones. i–k Representative images of Xist RNA FISH analysis of
clones Tg-E (87), Tg-X(109), Tg-X;8 (203b, 339), and Tg-12 (55, 228, 273, 292) after 5 days of doxycycline treatment. Xist, FITC; DNA is stained with
DAPI (blue). Scale bars represent 5 μm
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of chromosome 12 in clone 292 remained poor in fully
differentiated cells with only 10% of autosomal genes becoming
inactivated upon Xist induction (Fig. 3o).
We also studied the effects of Xist-mediated silencing upon
neuronal differentiation of Tg-X;8 and Tg-X clones, in which the
fusion between chromosomes X and 8 results in both partial
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Fig. 3 Xist-mediated silencing at different genomic loci. a, c, h Box plot showing the Cast/all ratio of X-linked genes for Tg-E a, Tg-X c, and Tg-X;8 h clones
after 5 days of doxycycline treatment in undifferentiated ESCs. e, g Box plot showing the Cast/all ratio of chromosome 12 and 8 genes in Tg-12 and Tg-X;8
clones after 5 days of doxycycline treatment in undifferentiated ESCs. *p< 0.05 Mann–Whitney U-test. b, d, f, i Bar graphs showing the percentage of
genes with a Δ ratio between 0.1 and 0.5 after 5 days of doxycycline treatment in undifferentiated ESCs. Δ ratio= (Cast/all ratio (−dox))—(Cast/all ratio
(+dox)). For each clone, data from two independent replicates are shown. j, k RT-PCR analysis followed by pyrosequencing at different time points after
doxycycline induction in undifferentiated ESC clones grown in serum + Lif conditions. Data for Rnf12 (Chr. X), Nampt, and Tcl1 are shown. l, m RT-PCR
analysis followed by pyrosequencing at different time points of neuronal differentiation of Tg-12 and Tg-E clones. Data for Rnf12 and Abcb7 (Chr. X) and
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induction at day 14 of neuronal differentiation. Δ ratio= (−Cast/all ratio (−dox))—(Cast/all ratio (+dox))
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trisomy of chromosome 8 genes and partial monosomy of X-
linked genes (Supplementary Fig. 1C). Forced induction of Xist in
Tg-X clones resulted in massive cell death upon differentiation,
which was not observed for Tg-X;8 clones, indicating rescue of
Tg-X;8 clones by inactivation of the translocated chromosome
(Fig. 4a). Indeed, all doxycycline-untreated Tg-X and Tg-X;8
clones showed skewed Xist expression from and inactivation of
the 129/Sv X chromosome that is fused to chromosome 8 in the
X;8 translocation product (Fig. 4b; Supplementary Fig. 5). This
was conﬁrmed by allele-speciﬁc RNA-seq analysis of Tg-X;8
neurons that were differentiated in the absence of doxycycline,
conﬁrming that Xist-mediated correction of the X;8 chromosomal
rearrangement is crucial for cell survival (Fig. 4c, d). In contrast,
wild-type ESCs show random XCI upon neuronal differentiation
(Fig. 4e). Since gain of extra chromosomes is usually better
tolerated than chromosomal loss37, silencing of the monosomic
X-linked genes on the 129/Sv chromosome rather than partial
trisomy of chromosome 8 is most likely responsible for the
lethality observed upon differentiation of Tg-X clones.
In conclusion, although ESC differentiation might stabilize
Xist-mediated silencing of X-linked genes, as seen upon neuronal
differentiation of Tg-E clones (Fig. 3l), it does not affect the
variability of Xist’s silencing efﬁciency in between different clones
with random integration of Xist transgenes on autosomes.
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Preferential inactivation of speciﬁc genes on chromosome X.
Next, we tested whether there are speciﬁc genes on chromosomes
X, 8, and 12 that are more prone to inactivation regardless of the
Xist transgene position along the chromosome. To this end, we
evaluated each gene in our allele-speciﬁc RNA-seq data sets. We
ﬁrst calculated the averaged allele-speciﬁc expression ratio for
each gene across all clones of each category. Second, we ranked all
X-linked and autosomal genes according to their general degree
of silencing upon doxycycline treatment. Finally, we divided
chromosomes X, 8, and 12 ranked genes into three categories:
(I) genes that are efﬁciently silenced, (II) genes that are partially
affected and (III) not silenced genes (Fig. 5a–c). Ranking genes in
separated data sets for chromosomes X, 12, and 8 allows us to
relate different silencing effects to genetic and epigenetic features
along each of the three chromosomes, and independently of the
generally more efﬁcient inactivation of chromosome X compared
to autosomes (Fig. 3). Thus, we tested whether its position in a
speciﬁc chromosomal region makes a gene more prone to either
becoming inactivated or to escape from Xist inactivation
(Fig. 5d–f; Supplementary Fig. 6). On chromosome 12, silenced,
partially affected, and not silenced genes are evenly distributed
along the entire chromosome length in all tested clones, regard-
less of Xist transgene position. Rather, it correlated with general
gene density (Fig. 5d). Similar results were obtained for chro-
mosome 8, with the exception of a slight tendency of strongly
silenced genes to deviate from the pattern observed for not
silenced and partially affected genes (Fig. 5e). This tendency most
likely reﬂects more efﬁcient inactivation of chromosome 8 genes
in proximity of the X;8 translocation breakpoint (Fig. 5e).
In contrast, differentially silenced genes are not homoge-
neously distributed along the X chromosome (Fig. 5f). Rather,
X-linked genes are organized in chromosomal blocks that behave
differently in terms of gene inactivation efﬁciency. Centromeric
genes are more prone to escape ectopic XCI compared to genes
located in the sub-centromeric region of chromosome X,
independently of where the Xist transgene was integrated on
the X chromosome or on the X;8 translocation product (Fig. 5f;
Supplementary Fig. 6A–C). These results indicate a fundamental
difference in the capacity for ectopic inactivation between
X-chromosomal and autosomal genes, and led us to hypothesize
that if XCI is artiﬁcially induced in undifferentiated ESC, it always
recapitulates endogenous XCI, independently of the locus on the
X chromosome from which Xist RNA is forced to spread. Indeed,
by comparing the ranked X-linked gene list with clusters of genes
that show different dynamics of silencing upon ESC differentia-
tion38, we found that 74% of early silenced genes correspond to
strongly silenced genes in our data set and 72% of the genes that
escape XCI overlap with our “not silenced” genes category
(Fig. 5g). Importantly, 95% of the early silenced genes were found
to be at least partially affected in our data set and only 5% of the
reported escaping genes showed any sign of silencing upon
ectopic XCI (Fig. 5g). Next, we addressed the question of whether
the evolutionary features of X-linked genes predispose them to
become inactivated or to escape XCI. X-linked genes can be
classiﬁed based on the X chromosome’s evolutionary history:
“old” genes are those found on chicken orthologous autosomes,
whereas “new” genes were exclusively added to the mammalian
X chromosome39–41. We mapped old and new X-linked genes
on the mouse X chromosome and we found that evolutionary
new genes are enriched in the centromeric region of the X
chromosome that is more prone to escape inactivation (Fig. 5f, h).
Our data therefore conﬁrm previous ﬁndings observed for the
human X chromosome42, indicating that the evolutionary history
of the X chromosome plays a role in establishing the path of
X-linked gene inactivation in XCI in mouse, which appears
independent of the position of Xist on the X chromosome.
Xist integration sites do not dictate silencing efﬁciency.
Depending on the transgene integration locus, chromosome 12
becomes poorly or more efﬁciently inactivated by ectopic Xist.
Thus, the different degree of chromosome-wide silencing might
rely on speciﬁc features of the transgene integration sites. We
therefore compared the Xist integration sites of Tg-12, Tg-X, and
Tg-X;8 clones along chromosomes 12, X, and 8. Among Tg-12,
clones 55 and 292 showed the most efﬁcient and poorest gene
silencing efﬁciency, respectively, and the genomic environment in
proximity of the transgene integration loci in these two clones
strongly differs in terms of gene density (Fig. 6a). In clone 292,
the Xist transgene was integrated in a gene desert of 2,1 Mb,
whereas clone 55 carries the transgene in a gene-rich chromo-
somal region (Fig. 6a). However, clone 228 is also integrated in a
gene-dense area but does not display more efﬁcient silencing
compared to clones 273 and 160, in which Xist is integrated in
gene-poor areas of chromosome 12. Moreover, when we looked at
the Xist integration sites in Tg-X and Tg-X;8 clones, all clones in
which Xist induction leads to efﬁcient inactivation of X-linked
genes, we found that the Xist transgenes were integrated in
both gene-dense (clones 86, 109, 267, and 203b) and gene-poor
(109, 85) areas of chromosome X and 8 (Fig. 6b, c). These
observations conﬁrm that the presence of X-linked speciﬁc
elements, rather than general genomic features such as gene
density, plays a major role in determining the efﬁciency of
chromosome-wide gene silencing.
Although long-range silencing appeared variable in between
different clones, we also found that genes in 4Mb regions around
the transgene integration site are always more efﬁciently
inactivated than genes in 40 and 200Mb regions (Fig. 6d, e),
regardless of the overall silencing efﬁciency achieved in different
clones. Thus, clones 55, 86, and 87 efﬁciently inactivate
chromosomes 12 and X, respectively, but genes in 2Mb regions
in close proximity of the Xist integration site even showed
stronger inactivation (Fig. 6d, e). Importantly, clone 292
showed poor chromosome-wide inactivation in both ESCs and
fully differentiated neurons but expression analysis of genes
lying in 4Mb region around the Xist transgene conﬁrmed that
ectopic Xist RNA is capable of inducing local gene silencing
(Fig. 6e).
Thus, ectopic silencing of genes in proximity of the Xist
transcription locus is achieved in all clones, whereas long-range
gene silencing is more efﬁcient for X-linked genes compared to
autosomal genes (Figs. 3, 6d), suggesting that other X-linked
DNA elements are likely to account for the efﬁcient inactivation
of genes that are not in direct proximity of Xist transcription
locus.
LINEs facilitate silencing of X-linked and autosomal genes.
Given the fact that LINEs are enriched on the X chromosome43,
we evaluated the contribution of LINEs to silencing efﬁciency in
our Xist-inducible system. LINEs are non-LTR retrotransposable
elements that account for up to 19% of the mouse genome44 and
the majority of which are unable to retrotranspose due to trun-
cation of their 5′ ends. Full-length young LINEs capable of ret-
rotransposition are still present in the mouse genome, although
their exact number remains unclear45. Both truncated and full-
length LINEs have been suggested to play a role in XCI; the ﬁrst
by participating in formation of a silent nuclear compartment
during XCI, and the latter one by promoting the inactivation of
genes that are prone to escape XCI16. To test whether truncated
and full-length LINEs facilitate Xist-mediated silencing in our
expression system, we looked at their enrichment in 1Mb regions
around the TSS of either “efﬁciently silenced”, “partially affected”,
and “not silenced” genes along chromosomes X, 12, and 8.
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This analysis indicated that LINE elements are enriched around
the TSS of efﬁciently silenced genes for all transgenic clones
(Fig. 6f–i). In contrast, not silenced genes cluster in LINE-poor
regions of chromosomes X, 12, and 8 (Fig. 6f–i). To exclude that
this correlation relies on the relative distribution of genes and
repetitive elements along the chromosome, we performed the
same analysis for short interspersed elements (SINEs), a different
class of non-LTR transposable elements that account for 8% of
the mouse genome44. We did not ﬁnd any enrichment of SINEs
around the TSS of efﬁciently silenced genes on chromosomes X,
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8, and 12 (Fig. 6j). Rather, SINE enrichment correlates with not
silenced genes on both chromosomes X and 12 (Fig. 6j).
Since the X chromosome is strongly enriched for LINEs, it is
nearly impossible to study Xist spreading from a LINE-poor area
of the X (Fig. 6g; Supplementary Fig. 7A). However, in both Tg-
12 clone 55 and 8 clones 267 and 203b Xist transgenes landed in
LINE-poor regions of chromosome 12 and 8 (Fig. 6f–h;
Supplementary Fig. 7) but chromosome-wide silencing is
efﬁciently achieved. Therefore, LINEs are enriched around genes
that are efﬁciently inactivated, but LINE density in close
proximity of the Xist transgene integration sites does not affect
Xist’s spreading efﬁciency. Since LINE elements are enriched in
gene-poor heterochromatic regions of genome, the observed
more efﬁcient inactivation of genes in LINE-rich domains might
reﬂect their already pre-repressed status. However, our data
indicate that the lower expressed autosomal genes do not
correspond to the genes that become more efﬁciently inactivated
upon Xist induction (Supplementary Fig. 7D), thus conﬁrming
the speciﬁcity of LINEs in facilitating the Xist-mediated silencing
of active genes. Taken together, our observations suggest that
truncated and full-length LINEs may facilitate Xist-mediated
transcriptional inactivation of both X-linked and autosomal
genes. In particular, the X chromosome-speciﬁc enrichment of
LINE elements might explain the efﬁcient long-range silencing of
X-linked genes in Tg-X;8 clones in which Xist RNA starts to
spread from the autosomal portion of the X;8 translocation
product.
Chromatin environment predisposes gene silencing. Next, we
asked whether the chromatin environment of X-linked and
autosomal genes in ESC prior to ectopic Xist induction might
predispose a speciﬁc gene to be either efﬁciently silenced or to
escape ectopic inactivation. Therefore, we looked at the enrich-
ment of both euchromatic and heterochromatic histone marks
around the TSS sites of X-linked and autosomal genes after
ranking them based on the degree of inactivation upon doxycy-
cline induction (Fig. 7a). To estimate the density of H3K27me3,
EZH2, H3K4me3, H3K27ac, and Ring1b 4 kb upstream and
downstream the TSS of (I) efﬁciently silenced, (II) partially
affected, and (III) not silenced genes we used published ChIP-seq
data obtained in ESCs46–50. Strongly inactivated genes on both
chromosomes X and 12 show enrichment of H3K27me3 and
Ring1b, and are depleted for active marks such as H3K4me3 and
H3K27ac around their TSS prior to inactivation. Interestingly,
depletion of H3K27ac seems speciﬁc for the X but not for genes
located on chromosome 12, suggesting that genes with less active
promoters are more likely targeted by the XCI machinery on the
X. Examination of average FPKM values of silenced, partially
silenced and not silenced genes indeed conﬁrms that efﬁciently
silenced X-linked genes display a signiﬁcantly lower expression
level, which is not observed for efﬁciently silenced autosomal
genes (Supplementary Fig. 7D). Our ﬁndings therefore indicate
the chromatin environment might be instructive for Xist to
function efﬁciently.
CTCF is enriched at the TSS of X-linked “not silenced” genes.
To date, several lines of evidence have suggested CTCF to be
involved in XCI escape. CTCF is enriched at transition regions
between silenced and escaping loci on the Xi27 and might act to
prevent spread of escape into neigbouring regions26. Moreover,
escaping genes tend to be the only regions that show accessible
chromatin on the Xi, and most of these accessible sites corre-
spond to CTCF sites51. Thus, we set out to address whether CTCF
binding plays a role in mediating XCI escape in our inducible
system. Using published data on ESCs CTCF proﬁles52,
we assessed the enrichment of CTCF around the TSS of both
X-linked and autosomal genes ranked by silencing efﬁciency
upon Xist induction. Our analysis showed enrichment of CTCF at
the TSS of “not silenced” X-linked genes relative to partially
affected and fully silenced genes. This enrichment was notably
absent for autosomal genes escaping XCI, pointing to an X
chromosome-speciﬁc role for CTCF in mediating escape from
XCI (Fig. 7b). Indeed, if active loci were causative of CTCF
binding, CTCF would be enriched at the TSS of both X-linked
and autosomal not silenced genes. Among the X-linked genes that
showed enrichment of CTCF at their TSS, we could detect eight
genes that were previously reported to escape XCI. Five of them,
Eif2s3x, Yipf6, Uba1, Rps4x, and Usp9x were deﬁned as escaping
genes in at least two independent studies28, 38, 42, 53, 54, and three
of them, Usp11, Haus7, and Apoo were reported to escape in one
study55. These ﬁndings suggest a very important role for CTCF
in maintaining escape from XCI during evolution of our sex
chromosomes.
Discussion
To investigate the mechanisms of Xist-mediated gene silencing,
we developed an inducible Xist expression system in ESCs.
Although previous studies have assessed Xist transgenic ESCs, all
these approaches were based on a limited number of genomic
integration sites, led to functional nullisomy of autosomal genes
upon Xist induction, and were performed in non-polymorphic
mouse strains16, 18, 36. The present study was designed to provide
a number of advantages over previous strategies involving Xist
transgenes. First, the use of F1 hybrid ESCs derived from 129/Sv
and Cast/Ei mouse strains56 provided a very high density of SNPs
and facilitated genome-wide expression analysis by allele-speciﬁc
RNA-seq33. Second, the use of female wild-type and aneuploid
ESC lines carrying either an extra copy of chromosome 12 or an
unbalanced X;8 translocation allowed us to induce XCI in ESCs
without triggering cell death, and to look at its impact during
differentiation. Third, by controlling Xist expression in isogenic
clones we could directly compare the efﬁciency of Xist-mediated
silencing between sets of ESCs that differ only in terms of
Xist transgene integration site on chromosomes X and autosomes.
Our studies indicate that Xist RNA can efﬁciently spread in cis
from different genomic locations, although its ability to trigger
gene silencing is position dependent. On the X chromosome,
XCI can be triggered from different loci always faithfully
recapitulating endogenous XCI: (I) “efﬁciently silenced” genes
highly overlap with genes that become inactivated ﬁrst upon
differentiation of wild-type female ESCs38, (II) a high overlap was
observed between genes that escape XCI38, and (III) evolutiona-
rily younger genes are more likely to escape XCI than older genes,
conﬁrming that XCI efﬁciency is inﬂuenced by the evolution of
the X chromosome42. On autosomes, the efﬁciency of Xist’s
silencing is heterogeneous in between different clones, in line with
many X;autosome translocation studies performed in somatic
cells11–13, 57, 58. Although all tested clones displayed gene silen-
cing in close proximity to the Xist transgene integration site,
comparison of the genomic environment of the Xist transgenes
indicated variability between transgenes. This variability might be
related to gene density, which we ﬁnd increased in the near
vicinity (2 Mb) of the transgene integration site for most trans-
genes that silence efﬁciently. Xist’s spreading on the X chromo-
some has previously been proposed to follow a two-step
mechanism, initially targeting gene-dense areas19, with a pre-
ference for genes located in spatial proximity to the Xist tran-
scription locus20. The variable silencing of autosomal Xist
transgenes may therefore be partially explained by local and distal
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differences in gene density in conjuction with a favorable spatial
landscape for Xist to function.
High-resolution maps of Xist RNA localization on the X
chromosome showed that LINE-rich domains are not coated by
Xist RNA at the onset of XCI19, 20, however, several studies have
reported that LINEs may play a role in XCI16, 18, 59, 60. Silent
LINEs have been implicated into the assembly of a nuclear het-
erochromatic compartment into which active genes are recruited
upon XCI3, 16. Also, LINE elements are enriched in heterochro-
matic G-dark positive bands61, and carry H3K9me3 at their
promoters45, 62. Interestingly, loss of H3K9me3 upon XCI results
in decreased gene silencing63, 64. Since Xist RNA directly interacts
with hnRNP K65, which is required for H3K9me3 deposition66,
LINEs might aid Xist recruitment into their heterochromatic
environment. Here, we have been able to systematically test
whether LINEs facilitate gene silencing in the context of different
Xist transgene integration sites, either on the X chromosome or
on autosomes. We found that LINEs are consistently enriched
around TSS of efﬁciently silenced genes. Such an enrichment was
not found for SINEs, highlighting the speciﬁc role of LINEs in
facilitating Xist function. Importantly, all autosomal Xist trans-
genes that led to efﬁcient chromosome-wide inactivation were
integrated in LINE-poor areas of chromosome 8 and 12. Thus,
LINEs may facilitate the propagation of silencing along the
chromosome, rather than working as X-linked-speciﬁc binding
sites for Xist spreading. Our ﬁndings may therefore be explained
by assuming that LINE dense X-linked sequences are required to
properly form a nuclear heterochromatic compartment, inde-
pendent of the Xist integration site, then resulting in efﬁcient
recruitment of genes for inactivation. This suggests that chro-
mosome 8 and 12, which display an overall reduced LINE density
may fail to create a functional nuclear heterochromatic com-
partment, leading to a reduced efﬁciency to silence autosomal
genes. Importantly, chromosome 8 genes in proximity of the X;8
translocation breakpoint, thus closer to X chromosomal, LINE-
rich DNA, appear to be more efﬁciently silenced than other
autosomal genes, which are closer to the Xist transcription locus.
This again highlights the role of the X-linked LINE-dense
environment in facilitating gene silencing.
Exhaustive analysis of multiple different Xist transgenic cell
lines indicated that X-linked and autosomal genes that are most
efﬁciently inactivated by Xist tend to show enrichment of both
PRC1 and PRC2 components, before Xist induction. Accordingly,
about half of the X-linked PRC2 sites that are acquired upon ESC
differentiation correspond to sites that were marked exclusively
by H3K27me3 in undifferentiated ESC67. Since PRC2 and PRC1
positively inﬂuence each others recruitment68, and Xist has been
reported to directly or indirectly interact with both repressive
complexes65, 69, the observed enrichment of polycomb complexes
at the TSS of silenced genes might be involved in Xist RNA or
PRC1/2 recruitment, or else in facilitating the Xist-mediated gene
silencing process. Interestingly, we ﬁnd X chromosome-speciﬁc
depletion of H3K27ac at TSSs of efﬁciently silenced genes,
revealing an epigenetic signature that might facilitate XCI and
explain the more efﬁcient inactivation of X-linked genes.
Finally, we found several known escapees in our “not silenced”
category of X-linked genes which correspond to genes that always
escape XCI regardless of the locus from which Xist starts
spreading, i.e., (I) its endogenous locus on the X, (II) several
different loci along the wild-type X chromosome, or (III) the
autosomal portion of the X;8 translocation product. These ﬁnd-
ings show that escaping loci have the intrinsic ability to con-
sistently resist XCI, similar to what was previously reported for
the Jarid1c locus25. Although escaping genes have been previously
found to co-localize with CTCF binding clusters on the Xi28,
it has been very difﬁcult to address whether CTCF binding itself
triggers escape from XCI or whether the transcriptional activity of
escaping genes is causative of the CTCF binding. Our results
indicate speciﬁc enrichment of CTCF at the TSS of X-linked but
not autosomal genes that escape ectopic XCI, thus excluding the
enrichment of CTCF to simply reﬂect the transcriptional activity
of not silenced genes. Importantly, X chromosome-speciﬁc
enrichment of CTCF at escaping loci also suggests that main-
tenance of CTCF binding upon XCI evolution might have
allowed clusters of escaping genes to resist the general collapse of
topologically-associated domains, a typical feature of the inactive
X chromosome51, 70. In contrast, autosomal genes have not been
selected in favor or against their degree of inactivation upon Xist
RNA spreading, thus explaining both the lack of differential
CTCF enrichment at the TSS of strongly inactivated and
not silent genes, and the less efﬁcient long-range silencing of
autosomal genes compared to X-linked genes.
The expansion of CTCF binding sites functionally relies on a
repeat-driven mechanism71. CTCF motifs were carried to over
thousands genomic locations in the mouse genome by transpo-
sition of SINE elements72. Thus, since CTCF binding prevents
both DNA methylation73 and the establishment of a repressive
chromatin environment74, carrying a CTCF motif within their
sequence have conferred SINE elements an evolutionary advan-
tage71. Indeed we observed a positive correlation between SINEs
and XCI escape, similar to a previous report studying human
somatic cells59. In the context of XCI, the SINE-driven expansion
of CTCF binding sites, together with the enrichment of CTCF at
the TSS of escaping genes might therefore explain the positive
correlation that we found between SINEs and genes that tend to
resist to ectopic Xist induction.
In summary, our data support a model where the X chromo-
some evolved speciﬁc genomic features facilitating efﬁcient XCI
and escape of XCI. The accumulation of LINEs facilitated silen-
cing by providing a structural basis for XCI to proceed, guided by
a chromatin landscape of genes subjected to XCI, while the X
chromosome-speciﬁc enrichment of CTCF at escaping loci may
enable them to resist Xist-mediated chromosome-wide inactiva-
tion (Fig. 7d). In conclusion, the ﬁndings we report here,
exploring Xist-mediated initiation and spread of XCI from
numerous different Xist transgenes, provide unique insights into
the genomic and epigenomic features that are required to enable
Xist RNA-mediated chromosome-wide silencing and local escape.
Methods
Recombinant BACs construction. The X-linked Cast/Ei BAC CH26-171B21
containing the Xist endogenous locus was modiﬁed by bacteria-mediated
homologous recombination30. The pTRE-DsRed-3-5-NEO targeting vector was
constructed starting from pTRE-Tight-BI-DsRed2 (Clontech). Homology arms and
kanamycin/neomycin resistance cassette ﬂanked by lox sites were ampliﬁed by PCR
from BAC CH26-171B21 and TOPO-Xist-GFP-NEO using primers listed in
Supplementary Table 1. Correctly recombined pTRE-Xist-CH26-171B21 BACs
were screened by PCR using primers listed in Supplementary Table 1. Similarly, the
M2rtTA transactivator was targeted at the ROSA26 endogenous locus of the 129/Sv
BAC RP24-140O11. The M2rtTA-ROSA26-NEO targeting vector was constructed
starting from the TOPO-KanaNEO plasmid. 3′ and 5′ homology arms were PCR
ampliﬁed from BAC RP24-140O11 and ROSA26-m2rtTA-Puro-Amp plasmid
using primers listed in Supplementary Table 1. Correctly recombined BACs
R26-M2rtTA-RP24-140O11 were screened by PCR using primers listed in
Supplementary Table 1.
ESCs culture and transgenic ESC lines generation. ESCs were grown either in
standard serum + LIF ESC medium conditions containing DMEM, 100 Uml−1
penicillin/streptomycin, 20% KnockOut Serum Replacement (Gibco), 0.1 mM
NEAA, 0.1 mM 2-mercaptoethanol, 5000 Uml−1 LIF, or in feeders-free 2i + LIF
conditions supplemented with 1 μM MEK inhibitor PD0325901 (Stemgent) and 3
μM GSK3 inhibitor CH99021 (Stemgent). Transgenic ESC lines were generated
using polymorphic F1 2–1 hybrid ESC lines (129/Sv-Cast/Ei)30. ESC clones were
transfected with 30 μg of recombinant BACs. BAC R26-M2rtTA-RP24-140O11
carrying the reverse tetracycline transactivator M2rtTA was targeted to the 129/Sv
chromosome 6 of three F1 2–1 ESC lines (40,XX, 40,XX,t(X;8), 41,XX,dup12). Loss
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of a MnlI RFLP upon homologous recombination was used to screen drug-resistant
clones for correct targeting events with primers listed in Supplementary Table 1.
Similarly, BAC pTRE-Xist-CH26-171B21 was used to target the endogenous locus
of the Cast/Ei X chromosome of 40,XX F1 2–1 lines, thus generating the Tg-E
clones. Loss of a Tsp509I RFLP was used to screen drug-resistant clones for correct
targeting events with primers listed in Supplementary Table 1. Correctly targeted
clones were screened by PCR for loss of one X chromosome by a Pf1MI RFLP
located in the X-linked gene Atrx using primers listed in Supplementary Table 1.
To generate clones Tg-12, Tg-X, and Tg-X;8 F1 2-1 ESC lines 40,XX,t(X;8) and 41,
XX,dup12 were transfected with BAC pTRE-Xist-CH26-171B21 and neomycin-
resistant clones were screened by DNA FISH. To induce Xist expression, ESC
medium was supplemented with 2 μg ml−1 doxycycline.
Fluorescent in situ hybridization. For DNA FISH, methanol acetic acid ﬁxed cells
were dropped on glass slides and incubated at 37° C 24 h. Slides were washed 10
min in 2× SSC buffer at 55 °C (1× SSC: 0.15 M NaCl, 0.015 M sodium citrate), and
5 min in 2× SSC buffer at room temperature before being dehydrate in a gradient of
70, 90, and 100% EtOH. Nick-labeled DNA probes (DIG or BIO Nick-translation
kit, Roche) were dissolved in hybridization mixture (50% formamide, 10% dex-
trane, 2× SSC, pH = 7.5) and 100 ng μl−1 mouse Cot-1 DNA (Thermo Fisher
Scientiﬁc) to a ﬁnal concentration of 1 ng μl−1. The probe mixture was applied to
the cells, covered with a glass coverslip, incubated 3′ at 75° C and let to cool down
for 30 min on the heating plate after having turned it off. Slides were then incu-
bated overnight at 37° C in a humid chamber ﬁlled with 50% formamide in 2× SSC
buffer. After hybridization, slides were washed for 10 min in 2× SSC buffer at room
temperature, two times 10 min in 0.1× SSC buffer at 55° C and 10 min in low-salt
buffer at room temperature (100 mM Tris, 150 mM NaCl, 0.05% Tween). Detection
was done by incubation with FITC-labeled anti-digoxigenin antibody (Roche,
11207741910, 1:100) and Alexa594-labeled Streptavidin (Thermo Fisher Scientiﬁc,
S11227, 1:100) in low-salt buffer containing 1% of low-fat milk for 60 min at 37° C.
Slides were washed for 10 min in low-salt buffer and mounted with ProLong Gold
Antifade with DAPI (Molecular Probes). The following BACs were used as probes:
CH26171B21 (Chr. X), RP23477B14 (Chr. 8), and RP24112A14 (Chr. 12).
For Xist RNA FISH, ESCs were ﬁxed for 10 min with 4% paraformaldehyde
(PFA)–PBS at room temperature, washed with 70% EtOH, permeabilized 4 min
with 0.2% pepsin at 37 °C and post-ﬁxed with 4% PFA–PBS for 5 min at room
temperature. Slides were washed twice with PBS and dehydrated in a gradient of
70, 90, and 100% EtOH. The Xist probe was a 5.5 kb BglII cDNA fragment covering
Xist exon 3–7. The probe was dig-labeled (DIG Nick-Translation Kit, Roche) and
dissolved in hybridization mixture (50% formamide, 2× SSC, 50 mM phosphate
buffer (pH 7.0), 10% dextran sulfate) and 100 ng μl−1 mouse Cot-1 DNA (Thermo
Fisher Scientiﬁc) to a ﬁnal concentration of 1 ng μl−1. After 5 min of denaturation,
the probe was pre-hybridized for 45 min at 37° C, and slides were incubated in a
humid chamber ﬁlled with 50% formamide in 2× SSC buffer at 37° C overnight.
After hybridization, slides were washed once in 2× SSC, three times in 50%
formamide-2× SSC, both at 37° C and twice in TST (0.1 M Tris, 0.15 M NaCl,
0.05% Tween 20) at room temperature. Blocking was done in BSA–TST for 30 min
at room temperature. Detection was done by subsequent steps of incubation with
anti-digoxigenin (Roche 11093274910, 1:500) and two FITC-labeled antibodies
(Roche 31627, 65-6111 1:250) in blocking buffer for 30 min at room temperature.
Coverslips were washed twice with TST between detection steps and once ﬁnally
with TS (0.1 M Tris, 0.15 M NaCl). Dehydrated coverslips were mounted with
ProLong Gold Antifade with DAPI (Molecular Probes).
ESCs differentiation. ESCs grown in conventional serum + LIF conditions were
pre-plated on cell culture dishes for 40 min and then seeded on feeders-free gelatin-
coated culture dishes containing EB differentiation medium (IMDM-glutamax,
15% fetal calf serum, 100 Uml−1 penicillin/streptomycin, 0.1 mM NEAA, and 50
μg ml−1 ascorbic acid). During differentiation, the culture medium was refreshed
daily. To induce neuronal differentiation, ESCs grown in feeders-free 2i conditions
were seeded at a density of 10,000 cells per cm2 on 10 μg ml−1 laminin-coated
(Sigma Aldrich, L2020) dishes in neuronal differentiation medium (50% Neuro-
basal (Gibco), 50% DMEM:F12 (Gibco), 100 Uml−1 penicillin/streptomycin, 1%
N-2 supplement (Gibco 17502-048), 2% B27 supplement (Gibco 17504-044), 2 mM
L-Glutamine (Gibco 25030081), and 0.05 mM 2-mercaptoethanol (Gibco
31350010). Cells were refreshed daily and neuronal medium was supplemented
with 250 nM retinoic acid between day 4 and day 8 of differentiation. After 8 days,
cells were split at low density and further cultured in neuronal medium to obtain
fully differentiated neurons around day 12–14 of differentiation.
Expression analysis. Cells were lysed by direct addiction of 500 μg of TRIZOL and
total RNA was extracted according to the manufacturer’s instructions (Invitrogen).
To remove genomic DNA contamination, samples were treated for 15 min at 37° C
with DNaseI (Invitrogen). Next, 1 μg of RNA was reverse transcribed by Super-
script II reverse transcriptase with random hexamers (Invitrogen). For quantitative
PCR and allele-speciﬁc quantitative PCR, gene expression levels were quantiﬁed
using 2× SYBR Green PCR Master Mix (Applied Biosystems) in a CFX384 Real-
Time machine (Bio-Rad) with primers listed in Supplementary Table 2. Expression
levels were normalized to actin b using the ΔCT method. To perform
pyrosequencing, oligos for real-time PCR ampliﬁcation and sequencing were
designed according to the PyroMark Assay Design software guidelines and are
listed in Supplementary Table 4. Successfully ampliﬁed PCR products were puriﬁed
and annealed with the sequencing primer for pyrosequencing using the PyroMark
Q24 (Qiagen).
Targeted locus ampliﬁcation analysis. In brief, ES cells were crosslinked using
formaldehyde and DNA was digested with NlaIII. The samples were ligated,
crosslinks reversed, and the DNA puriﬁed. To obtain circular chimeric DNA
molecules for PCR ampliﬁcation, the DNA molecules were trimmed with NspI and
ligated at a DNA concentration of 5 ng μl−1 to promote intramolecular ligation.
After ligation, the DNA was puriﬁed, and six 25 μl PCR reactions, each containing
100 ng template, were pooled for sequencing. All used oligos are listed in Sup-
plementary Table 3. PCR products were NGS library prepped using Illumina
NexteraXT NGS library preparation according to manufacturer’s protocols. We
performed sequencing of targeted locus ampliﬁcation libraries on the Illumina
MiSeq platform pooling ~20 libraries per V2 PE150 sequencing run. Reads were
mapped using split-read aware alignment with BWA mapping software.
Density plots. Available ChIP-seq data sets were retrieved from the Gene
Expression Omnibus (GEO) database and mapped to reference genome mm10 as
previously described75, i.e., sequences with low complexity that are unlikely to map
uniquely to the genome were removed from the described ChIP-seq data sets using
prinseq-lite with the dust method with 7 as threshold. The remaining sequences
with a Phred score< 70 were mapped to the mm10 reference genome using Bowtie
v0.12.7, where a seed length of 36 was used in which we allowed a maximum of two
mismatches. If a read had multiple alignments, only the best matching read was
reported. Duplicated reads were removed. ChIP-seq data sets with multiple repli-
cates were merged. For the ChIP-seq density plots mapped reads were counted in
bins of 200 bp in 8 kb centered on the TSSs of genes. Reads were normalized to
RPKM. Genes were divided in categories and average RPKMs were plotted.
Box plots. The positions of all LINE and SINE elements along the entire length of
chromosomes X, 12, and 8 were obtained from the mm10 repeat masker table
(UCSC genomic browser). LINE and SINE elements were counted in 1Mb regions
centered on the TSSs of genes. Genes were divided in categories and plotted in
box plots.
RNA sequencing. RNA samples were prepared with the Truseq RNA kit,
sequenced according to the Illumina TruSeq v3 protocol on the HiSeq2000 with a
single 43 bp read and 7 bp index. Allele-speciﬁc analysis was performed as pre-
viously described with minor modiﬁcations33. Mouse Cast/Ei and 129/Sv genomes
were built from the Mouse Sanger database project (version 3) and Mouse mm10
reference genome. Raw sequencing reads were aligned to both genomes with the
TopHat aligner (v2.0.6). RefSeq gene annotation from UCSC genome browser was
used as the reference for known transcripts. For each sample, mapping results
against both parental genomes were merged to keep the best alignment for each
read. Only unique alignments were reported for downstream analysis. At each SNP
site, the number of bases matching each genotype was counted to obtain the
abundance of the 129 and Cast alleles (samtools mpileup v0.1.19). The allelic
counts per gene were then estimated by summing up the number of 129- and Cast-
speciﬁc reads of all exonic SNPs within the gene. Genes containing a single-
polymorphic site were included in the analysis only when they show a coverage
higher than eight reads, whereas for genes carrying multiple informative SNPs the
coverage threshold was of ﬁve reads per polymorphic site.
Data availability. All sequencing data that support the ﬁndings of this study have
been deposited in the National Centre for Biotechnology Information GEO and are
accessible through the GEO series accession number GSE92894. All other data that
support the ﬁndings of this study are available from the corresponding authors
upon reasonable request.
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